Web Results

Gefitinib

en.wikipedia.org/wiki/Gefitinib

For the genus of moth see Iressa (moth). Gefitinib. Gefitinib structure.svg · Gefitinib ball-and-stick.png · Systematic (IUPAC) name.

Gefitinib - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/gefitinib

This page contains brief information about gefitinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...

Gefitinib: MedlinePlus Drug Information - National Library of Medicine

www.nlm.nih.gov/medlineplus/druginfo/meds/a607002.html

Dec 15, 2015 ... Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is ...

Gefitinib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/gefitinib.html

Easy to read patient leaflet for gefitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Gefitinib - Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/gefitinib.aspx

(jef-it-i-nib). Trade name: Iressa<sup>®</sup>. Drug type: Gefitinib is a targeted therapy. It is classified as a signal transduction inhibitor (epidermal growth factor receptor ...

FDA Approves New Use of Iressa (Gefitinib) for EGFR-mutated Lung ...

www.cancer.org/cancer/news/news/fda-approves-new-use-of-iressa-gefitinib-for-egfr-mutated-lung-cancer

Jul 20, 2015 ... The US Food and Drug Administration (FDA) has approved Iressa (gefitinib) for the primary treatment of non-small cell lung cancer that has ...

gefitinib, Iressa (Discontinued in the US): Drug Facts, Side Effects ...

www.medicinenet.com/gefitinib/article.htm

Jul 9, 2015 ... Exposes the medication gefitinib (Iressa), a drug used as monotherapy for lung cancer that has not responded to chemotherapy.

Press Announcements > FDA approves targeted therapy for first-line ...

www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm454678.htm

Jul 13, 2015 ... The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell ...

Approved Drugs > Gefitinib (Iressa) - FDA

www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm454692.htm

Jul 13, 2015 ... On July 13, 2015, the U. S. Food and Drug Administration approved gefitinib ( IRESSA) for the treatment of patients with metastatic non-small ...

NDA 21-399/S-008 Page 3 FOR ONCOLOGY USE ONLY - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2005/021399s008lbl.pdf

(gefitinib tablets) contain 250 mg of gefitinib and are available as brown film- coated tablets for daily oral administration. Gefitinib is an anilinoquinazoline with the ...

More Info

IRESSA® (gefitinib) | Information and resources

www.iressa-usa.com

Learn about IRESSA® (gefitinib), now approved for first-line treatment of EGFR mutation–positive patients with metastatic NSCLC.

Gefitinib (Iressa) | Cancer Research UK

www.cancerresearchuk.org

Oct 8, 2015 ... Read about the cancer treatment drug gefitinib, also called Iressa, including what it is, how it works and possible side effects.

Iressa (gefitinib) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com

Iressa (gefitinib) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Iressa is used to treat non-small cell lung cancer.